[go: up one dir, main page]

FR1261M - Suspensions stabilisées d'érythromycine. - Google Patents

Suspensions stabilisées d'érythromycine.

Info

Publication number
FR1261M
FR1261M FR860361A FR860361A FR1261M FR 1261 M FR1261 M FR 1261M FR 860361 A FR860361 A FR 860361A FR 860361 A FR860361 A FR 860361A FR 1261 M FR1261 M FR 1261M
Authority
FR
France
Prior art keywords
erythromycin
stabilized suspensions
suspensions
stabilized
erythromycin stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR860361A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to FR860361A priority Critical patent/FR1261M/fr
Application granted granted Critical
Publication of FR1261M publication Critical patent/FR1261M/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
FR860361A 1960-02-04 1961-04-29 Suspensions stabilisées d'érythromycine. Active FR1261M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR860361A FR1261M (fr) 1960-02-04 1961-04-29 Suspensions stabilisées d'érythromycine.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6594A US3097135A (en) 1960-02-04 1960-02-04 Erythromycin suspensions and method of stabilizing the same
FR851433 1961-02-02
FR860361A FR1261M (fr) 1960-02-04 1961-04-29 Suspensions stabilisées d'érythromycine.

Publications (1)

Publication Number Publication Date
FR1261M true FR1261M (fr) 1962-04-24

Family

ID=21721636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR860361A Active FR1261M (fr) 1960-02-04 1961-04-29 Suspensions stabilisées d'érythromycine.

Country Status (4)

Country Link
US (1) US3097135A (fr)
ES (1) ES264629A1 (fr)
FR (1) FR1261M (fr)
GB (1) GB907430A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518380A1 (de) * 1964-09-02 1969-08-07 Tarchominskie Zaklad Farma Verfahren zur Herstellung von Erythromycinestern
US4146648A (en) * 1977-07-14 1979-03-27 Bristol-Myers Company Chemotherapeutic composition
US5114929A (en) * 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
EP1562543A1 (fr) * 2002-11-21 2005-08-17 J.P.M.E.D. Ltd. Compositions servant a traiter la peau et la membrane muqueuse infectees et comprenant un agent anti-microbien et une huile essentielle
CN114208874A (zh) * 2021-11-12 2022-03-22 山东福瑞达生物科技有限公司 一种油溶型纳他霉素制剂及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1924990A (en) * 1929-04-08 1933-08-29 Benjamin R Harris Stabilized egg product
US2372807A (en) * 1941-07-05 1945-04-03 Atlas Powder Co Absorption bases
US2385262A (en) * 1941-12-10 1945-09-18 Curtis David Therapeutic-anesthetic preparations
US2448180A (en) * 1943-06-30 1948-08-31 Abbott Lab Medicinal composition
US2532206A (en) * 1946-07-01 1950-11-28 Vodol Company Ointment base of glycerine with phosphatide and petrolatum
US2529461A (en) * 1949-04-30 1950-11-07 Sharp & Dohme Inc Emulsions
US2675343A (en) * 1951-12-18 1954-04-13 Smith Kline French Lab Emulsion-forming liquid product
US2919230A (en) * 1953-10-29 1959-12-29 Rohm & Haas Hydrophilic base therapeutic compositions comprising cation-exchange resin
GB759577A (en) * 1953-12-17 1956-10-17 Bristol Lab Inc Oral therapeutic preparations containing coconut oil
US2820741A (en) * 1954-04-29 1958-01-21 Abbott Lab Aluminum aspirin granulation and method for making
US2916416A (en) * 1955-06-30 1959-12-08 Bristol Lab Inc Aspirin-modified coconut oil liquid suspensions
US2809895A (en) * 1955-07-05 1957-10-15 Sunkist Growers Inc Solid flavoring composition and method of preparing the same
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US2914443A (en) * 1958-03-31 1959-11-24 Abbott Lab Ointment
US2975099A (en) * 1958-06-25 1961-03-14 Upjohn Co Polyethylene glycol suppository bases

Also Published As

Publication number Publication date
GB907430A (en) 1962-10-03
US3097135A (en) 1963-07-09
ES264629A1 (es) 1961-06-16

Similar Documents

Publication Publication Date Title
BE614728A (fr) Technique d'attaque.
FR1426M (fr) 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6.
FR1417M (fr) 2-cyano-3-oxo-stéroides.
FR1376M (fr) Hydrindene-sulfonylurées.
FR1261M (fr) Suspensions stabilisées d'érythromycine.
DK104277C (da) Termokopieringsmaskine.
BE600819A (fr) Solutions d'hydroxy-polymères
FR1148M (fr) Benzo-1,3-oxazino-diones-(2,4).
FR1170M (fr) Nouveaux dérives d'imidazoline.
BE606740A (fr) Agents d'éclaircissement.
DK105182C (da) Lynlås.
FR2690M (fr) Méthoxy-3α méthyl-17α 5&alpha-androstanol-17β.
FR1697M (fr) 17 β-hydroxy-17 α-méthyl-2-oxa-3-oxo-5 α-androstane.
FR1286117A (fr) Solutions d'hydroxy-polymères
FR29M (fr) Chlorobenzylate de la n-diéthylaminoéthyl-oxy-3 naphtylamide-2.
BE584654A (fr) Mécanismes d'évaluation Perfectionnés.
FR1321M (fr) 3,20-bisoximes de prégnanes.
BE586550A (fr) Copolymères d'aminosilicium-alkylsilicate.
BE606432A (fr) Joints d'espacement.
FR2605M (fr) 6,16-diméthyl-15-déhydro-stéroides.
DK92723C (da) Si.
FR2301M (fr) Dichloro-16 alpha, 17 alpha-alkylidenedioxyprégnadienes.
BE586687A (fr) Classeur-distributer de monnaie.
BE596898A (fr) Mécanisme d'embrayage.
FR1482M (fr) La n-p-toluene-sulfonyl-n-beta-méthylsulfinyléthyl-urée.